Format

Send to

Choose Destination
J Hepatol. 2018 Jun;68(6):1313-1315. doi: 10.1016/j.jhep.2018.03.010. Epub 2018 Apr 3.

A sofosbuvir-based quadruple regimen is highly effective in HCV type 4-infected Egyptian patients with DAA treatment failure.

Author information

1
Molecular Physiology Division, Faculty of Science, Beni-Suef University, Egypt. Electronic address: adel_men2020@yahoo.com.
2
Tropical Medicine Department, Faculty of Medicine, Beni-Suef University, Egypt.
3
Biochemistry Division, Chemistry Department, Faculty of Science, Beni-Suef University, Egypt.
4
Biotechnology Department, Faculty of Postgraduate Studies for Advanced Science, Beni-Suef University, Egypt.

KEYWORDS:

Chronic hepatitis C; Daclatasvir; Retreatment; Ribavirin; Simeprevir; Sofosbuvir

PMID:
29625827
DOI:
10.1016/j.jhep.2018.03.010

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center